Clinical trial
Efficacy and pharmacokinetics of a switch from a regimen consisting of emtricitabine, nevirapine and tenofovir to rilpivirine, emtricitabine and tenofovir in virologically suppressed HIV-1 infected patients.
To evaluate the safety of a switch from nevirapine to rilpivarine.
| Category | Value |
|---|---|
| Study start date | 2012-08-30 |